Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2006-09-30
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Then the patients will be given pain relif in form of injection of sumatriptan and the effect of this will also be registered via measuring the BOLD response at the RIO's previously defined. A 3-Tesla MRI scanner will be used in this trail.
This study will give us key knowledge of the trigeminal pain pathway and the central processing i.e sensitization during a migraine attach.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide
NCT07021859
Stimulation-evoked Calcitonin Gene-Related Peptide (CGRP) as Biomarker of Migraine
NCT05768828
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
infusion of calcitonin gene related peptide (CGRP)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No less then 1 migraine attach pr month and no more then 6 attaches per month.
* Weight 50-100 kg.
* Women must be using secure birthcontrol.
Exclusion Criteria
* All other prim. og sec. headache types then migraine without aura.
* Daily use of medication other then birthcontrol pills.
* Pregnant and lactation women.
* Headache on the trail day or 5 days previous to the trail day.
* Contraindications to MRI-scans.
* Hypertension or hypotension.
* Known heart or lung condition.
* Mental illness or substance abuse.
* Other considerable conditions judged by the including doctor.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Headache Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neurological Dep. University of Copenhagen, Denmark, Glostrup Hospital.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Messoud Ashina, MD,PH.d
Role: STUDY_CHAIR
Danish Headache Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Headache Center, Neurological Dep. Glostrup hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA-20060083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.